Report of the GUDID Clinically Relevant Size (CRS) Work Group

By AHRMM

Related Resources

Letter/Comment
The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Fo
Advisory
Medical Device Tax Next Steps
The medical device excise tax is a feature of the Affordable Care Act. It is important to be knowledgeable about the tax and its effects.
Request for Proposals (RFP)
Wholesale Pharmacy Distributor
A sample of wholesale pharmacy distributor request for proposal.
Advisory
Hospital Compare: CMS Suspends Display of Hospital-Acquired Conditions Data
Hospital Compare: CMS Suspends Display of Hospital-Acquired Conditions Data
Letter/Comment
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult
Recent Guidance on Meaningful Use of EHRs Makes Compliance More Difficult.
Letter/Comment
AHRMM Comment Letter to FDA Regarding the Draft Guidance for Industry on the Global Unique Device Identification Database (GUDID)
On November 21, 2013, AHRMM submitted electronically